h8

H8-A5, a HDAC8 inhibitor, shows antiproliferation activity in MDA-MB-231 cancer cells.

H-8 hydrochloride is a reversible and ATP-competitive PKA inhibitor. It can be used to study metabolic diseases.

PROTAC(H-PGDS)-8 is a PROTAC degrader targeting Hematopoietic prostaglandin D synthase (H-PGDS), exhibiting an IC50 of 0.14 μM [1].

(1'R,3a'R,8a'S,9'S,9a'S)-1'-Methyl-3'-oxo-N,N-diphenyl-3',3a',5',7',8',8a',9',9a'-octahydro-1'H-spiro[[1,3]dioxolane-2,6'-naphtho[2,3-c]furan]-9'-carboxamide is a useful organic compound for research related to life sciences. The catalog number is T67324 and the CAS number is 900160-98-7.

Pyridinium, 1,1'-(thiodimethylene)bis(4-formyl-, dichloride, dioxime is a bioactive chemical.

ZH8651, a TAAR1 agonist, activates both Gs and Gq signaling pathways and has potential applications in schizophrenia research [1].

ZH8667 is a TAAR1-Gs agonist that holds potential for schizophrenia research [1].

LH846 is a selective inhibitor of CK1δ with IC50 values of 290 nM for CK1δ, 1.3 μM for CK1ε, and 2.5 μM for CK1α, and exhibits no inhibitory activity at CK2.

ZH8659 is a Gq agonist targeting the trace amine-associated receptor 1 (TAAR1) and has potential applications in schizophrenia research [1].

IDH889 is a brain penetrant, an allosteric and mutant specific IDH1 inhibitor. IDH889 has effective selectivity for IDH1 R132* mutations (IC50s: 0.02 μM, 0.072 μM, and 1.38 μM for IDH1R132H, IDH1R132C, and IDH1wt).

BtGH84 Activator I is a BtGH84 activator. It is the small molecule activator of a glycoside hydrolase.

Ginsenoside Rh8 is a natural product.